About this trial

This study is a multi-centre prospective observational cohort study recruiting patients with 5-30mm solid and part-solid pulmonary nodules that have been detected on CT chest scans performed as part of routine practice. The aim is to determine whether physician decision making with the AI-based LCP tool, generates clinical and health-economic benefits over the current standard of care of these patients.

Eligibility criteria

Qualifiers

Are aged 35 years or above

is not fully calcified

Is 5-30mm inclusive in maximum axial diameter for the whole lesion measured using manual electronic callipers

Is of a type that meets VNC instructions for use

Disqualifiers

Have received a diagnosis for cancer in the last 5 years

Have thoracic implants that impact the image appearance of the nodule

Have more than five reported pulmonary nodules of any size or type excluding fully calcified nodules (this criterion is used as a proxy due to the risk of being an infection or metastasis)

Are already undergoing follow-up according to pulmonary nodule management standard care

Trial design

Treatments tested in this trial

  • Not listed

Trial groups

No trial groups listed

Locations

10
Betsi Cadwaladr University Health Board Bangor United Kingdom
Frimley Health NHS Foundation Trust (Wexham Park Hospital) Frimley United Kingdom
Leeds Teaching Hospitals NHS Trust Leeds United Kingdom
King's College Hospital NHS Foundation Trust London United Kingdom

Sponsors and collaborators

Nottingham University Hospitals NHS Trust

Lead sponsor

Optellum Ltd.

Collaborator